PD-1/PD-L1 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for PD-1/PD-L1 inhibitor (unspecified), covering 2024-09-19 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy [Phase 1]